Union européenne - roumain - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - alte medicamente pentru sistemul nervos - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Union européenne - roumain - EMA (European Medicines Agency)

recordati rare diseases - ibuprofen - ductus arteriosus, brevet - terapia cardiacă - tratamentul unui arterios ductus al ductului arteriosus semnificativ la hemodinamică la sugarii prematuri nou-născuți mai mici de 34 săptămâni de vârstă gestațională.

Union européenne - roumain - EMA (European Medicines Agency)

tesaro bio netherlands b.v. - rolapitant - vomiting; nausea; cancer - antiemetice și medicamente pentru combaterea grețurilor, - prevenirea greutății și a vărsăturilor întârziate asociate cu chimioterapia cancerului emetogenic la adulți. varuby este administrat ca parte a terapiei combinate.

Union européenne - roumain - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - brexpiprazole - schizofrenie - psiholeptice - tratamentul schizofreniei.

Union européenne - roumain - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - fibroză chistică - alte produse ale sistemului respirator - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Union européenne - roumain - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artrita, reumatoida - imunosupresoare - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Moldavie - roumain - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

farmaco sa, im - sildenafilum - comprimate - 35 mg

Moldavie - roumain - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

farmaco sa, im - sildenafilum - comprimate - 70 mg

Moldavie - roumain - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - lisinoprilum - comprimate filmate - 160 mg

Moldavie - roumain - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - valsartanum - comprimate filmate - 80 mg